ScienceDaily (Sep. 24, 2008) — The most popular treatment for H pylori is triple therapy but resistance to Clarithromycin is reducing its effectiveness. Courses using four drugs have been known to be more successful but are used less popular because of their side-effects. While, what is the best way for treating H pylori-related diseases.

A new research article addresses this question. The research team led by Prof. Mr Siok Ching from United Kingdom compared a lansoprazole-based triple versus quadruple therapy for H pylori eradication with emphasis on side effect profile, patient compliance and eradication rate at a rural district general hospital in Wales, United Kingdom.

Overall the treatment of H Pylori using both three drugs and four drugs are still highly effective in rural North Wales (92%), however, almost all (97%) of the patients who managed to complete the course of four tablets got rid of the infection.

Authors feel that treatments with four drugs remain the best option for white Caucasians in rural UK. Patients need educating about the side effects of the drugs and the reasons for treatment so that they can reap the full benefits.

They concluded that one-week triple and quadruple therapies have similar intention-to-treat eradication rates. Certain side effects are more common with quadruple therapy, which can compromise patient compliance. Patient education or modifications to the regimen are alternative options to improve compliance of the quadruple regimen.

The side effects may be reduced by replacing metronidazole with amoxycillin but patients should be better educated about the side effects in order to improve compliance and cure rates.

Journal reference:

1. Ching SS, Sabanathan S, Jenkinson LR. Treatment of H pylori in surgical practice: A randomised trial of triple versus quadruple therapy in a rural district general hospital. World Journal of Gastroenterology, 28 June 2008; 14(24): 3855-3860 [link]

Email or share this story:  

Related Stories

Immune Cells May Induce Gastritis During H. Pylori Infection (May 27, 2008) — Researchers have examined the inflammatory response induced by macrophages that may contribute to the development of gastritis during Helicobacter pylori infection in mice. H. pylori is the causative ...  > read more

Cow Protein Aids In Treatment Of Gastrointestinal Disorder (May 17, 2007) — Recent evidence suggests that therapy currently used to treat Helicobacter pylori (H. pylori) infection, a major cause of upper gastrointestinal disorders, is unsuccessful in around 25 percent of ...  > read more

Combined Immunization Methods May Offer Long-Term Protection Against H. Pylori Infection (July 17, 2007) — New immunization methods offer long-term protection against H. pylori in humans and may contribute to a possible ulcer vaccine in the future say researchers from the University of California, ...  > read more

Helicobacter Pylori Help Their Cause By Inducing The Expression Of Molecules To Which They Bind (May 15, 2008) — The bacterium Helicobacter pylori infects various parts of the stomach and small intestine, and chronic infection with H. pylori can cause stomach cancer. New insight into the mechanisms by which H. ...  > read more

Search ScienceDaily

Sick of Strep Throat